human huvec nucleofector kit Search Results


90
Lonza nucleofection buffer human t cell nucleofector kit
Nucleofection Buffer Human T Cell Nucleofector Kit, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+huvec+nucleofector+kit/pm32239644-366-16-21?v=Lonza
Average 90 stars, based on 1 article reviews
nucleofection buffer human t cell nucleofector kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Lonza human stem cell nucleofector® kit 2
Human Stem Cell Nucleofector® Kit 2, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+huvec+nucleofector+kit/pmc09450964-67-0-7?v=Lonza
Average 90 stars, based on 1 article reviews
human stem cell nucleofector® kit 2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Lonza human aortic smooth muscle cell nucleofector kit cc-2571
Human Aortic Smooth Muscle Cell Nucleofector Kit Cc 2571, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+huvec+nucleofector+kit/pmc04540143-61-2-10?v=Lonza
Average 90 stars, based on 1 article reviews
human aortic smooth muscle cell nucleofector kit cc-2571 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Lonza human umbilical-vein endothelial cells (huvecs
Uptake and transfer of CD34Exo and exosomal miRNAs <t>by</t> <t>endothelial</t> cells in vitro and in vivo. Flow cytometry analysis of CD34+ cells (A) or exosomes isolated from CD34+ cells (B), transfected as indicated; confocal image of <t>HUVECs</t> treated with Cy3miRNA-CD34Exo (C); flow cytometry analysis of single cell suspensions from post-ischemic hindlimb tissue injected with R-PE-CD34Exo at 2h (D); % of cells uptaking exosomes (PE) from total number of each cell types quantified from Figure 5D (E), (n=3–5, *p<0.05).
Human Umbilical Vein Endothelial Cells (Huvecs, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+huvec+nucleofector+kit/pmc05420547-113-0-5?v=Lonza
Average 90 stars, based on 1 article reviews
human umbilical-vein endothelial cells (huvecs - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Lonza dermal microvascular endothelial cells
Uptake and transfer of CD34Exo and exosomal miRNAs <t>by</t> <t>endothelial</t> cells in vitro and in vivo. Flow cytometry analysis of CD34+ cells (A) or exosomes isolated from CD34+ cells (B), transfected as indicated; confocal image of <t>HUVECs</t> treated with Cy3miRNA-CD34Exo (C); flow cytometry analysis of single cell suspensions from post-ischemic hindlimb tissue injected with R-PE-CD34Exo at 2h (D); % of cells uptaking exosomes (PE) from total number of each cell types quantified from Figure 5D (E), (n=3–5, *p<0.05).
Dermal Microvascular Endothelial Cells, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+huvec+nucleofector+kit/pmc03069101-99-24-19?v=Lonza
Average 90 stars, based on 1 article reviews
dermal microvascular endothelial cells - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Lonza human coronary artery endothelial cells (hcaecs
Overexpression and secretion of fatty acid–binding protein 4 (FABP4) in vascular endothelial cells. A and B, Gene (A) and protein (B) expression levels of FABP 4 in <t>human</t> <t>coronary</t> artery endothelial cells ( <t>HCAECs</t> ) treated with 50 ng/mL of vascular endothelial growth factor ( VEGF ) for 24 hours or 100 μmol/L H 2 O 2 for 1 hour followed by 23‐hour incubation in normal culture media after washing were determined by quantitative real‐time polymerase chain reaction (n=3 in each group) and Western blot analysis, respectively. * P <0.05 vs control. C, Experimental design of adenovirus‐mediated overexpression in HCAECs using adenovirus vector of FABP 4 (Ad‐ FABP 4) or empty sequence (Ad‐Control) ( HCAEC ‐ OE ). D, Gene expression of FABP 4 in HCAEC ‐ OE (n=6 in each group). * P <0.05 vs Ad‐Control. E, Representative Western blot analysis of FABP 4 in HCAEC ‐ OE . F, Western blot analysis of nitric oxide synthase ( NOS 3) and phosphorylated NOS 3 ( pS 1177) in HCAEC ‐ OE treated with 0.5 μmol/L insulin or 50 ng/mL VEGF for 0.5 hours (n=3 in each group). * P <0.05. G and H, Gene expression of inflammatory cytokines (G) and adhesion‐related molecules (H) in HCAEC ‐ OE (n=6 in each group). * P <0.05 vs Ad‐Control. I, Western blot analysis of FABP 4 (exposure: light, L; dark, D) and GAPDH was performed using the cell lysate ( CL ) and conditioned medium ( CM ) of HCAECs supplemented with 0.5% BSA in the absence and presence of 10 μmol/L isoproterenol for 6 to 24 hours (n=3 in each group). * P <0.05. J, Secretion of FABP 4 for 24 hours in HCAEC ‐ OE measured using an enzyme‐linked immunosorbent assay kit (n=3 in each group). Values were normalized to total protein concentration of the cell lysate. * P <0.05 vs Ad‐Control. AU indicates arbitrary unit; Icam1, including intracellular adhesion; IL, interleukin; Itga5, integrin a 5; Itgb3, integrin b 3; Mcp1, monocyte chemotactic protein‐1; Sele, selectin E; Tnfa, tumor necrosis factor α.
Human Coronary Artery Endothelial Cells (Hcaecs, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+huvec+nucleofector+kit/pmc05634290-72-0-17?v=Lonza
Average 90 stars, based on 1 article reviews
human coronary artery endothelial cells (hcaecs - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Lonza human pasmcs
Overexpression and secretion of fatty acid–binding protein 4 (FABP4) in vascular endothelial cells. A and B, Gene (A) and protein (B) expression levels of FABP 4 in <t>human</t> <t>coronary</t> artery endothelial cells ( <t>HCAECs</t> ) treated with 50 ng/mL of vascular endothelial growth factor ( VEGF ) for 24 hours or 100 μmol/L H 2 O 2 for 1 hour followed by 23‐hour incubation in normal culture media after washing were determined by quantitative real‐time polymerase chain reaction (n=3 in each group) and Western blot analysis, respectively. * P <0.05 vs control. C, Experimental design of adenovirus‐mediated overexpression in HCAECs using adenovirus vector of FABP 4 (Ad‐ FABP 4) or empty sequence (Ad‐Control) ( HCAEC ‐ OE ). D, Gene expression of FABP 4 in HCAEC ‐ OE (n=6 in each group). * P <0.05 vs Ad‐Control. E, Representative Western blot analysis of FABP 4 in HCAEC ‐ OE . F, Western blot analysis of nitric oxide synthase ( NOS 3) and phosphorylated NOS 3 ( pS 1177) in HCAEC ‐ OE treated with 0.5 μmol/L insulin or 50 ng/mL VEGF for 0.5 hours (n=3 in each group). * P <0.05. G and H, Gene expression of inflammatory cytokines (G) and adhesion‐related molecules (H) in HCAEC ‐ OE (n=6 in each group). * P <0.05 vs Ad‐Control. I, Western blot analysis of FABP 4 (exposure: light, L; dark, D) and GAPDH was performed using the cell lysate ( CL ) and conditioned medium ( CM ) of HCAECs supplemented with 0.5% BSA in the absence and presence of 10 μmol/L isoproterenol for 6 to 24 hours (n=3 in each group). * P <0.05. J, Secretion of FABP 4 for 24 hours in HCAEC ‐ OE measured using an enzyme‐linked immunosorbent assay kit (n=3 in each group). Values were normalized to total protein concentration of the cell lysate. * P <0.05 vs Ad‐Control. AU indicates arbitrary unit; Icam1, including intracellular adhesion; IL, interleukin; Itga5, integrin a 5; Itgb3, integrin b 3; Mcp1, monocyte chemotactic protein‐1; Sele, selectin E; Tnfa, tumor necrosis factor α.
Human Pasmcs, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+huvec+nucleofector+kit/pm32506676-237-0-2?v=Lonza
Average 90 stars, based on 1 article reviews
human pasmcs - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Lonza neonatal human dermal fibroblasts
Overexpression and secretion of fatty acid–binding protein 4 (FABP4) in vascular endothelial cells. A and B, Gene (A) and protein (B) expression levels of FABP 4 in <t>human</t> <t>coronary</t> artery endothelial cells ( <t>HCAECs</t> ) treated with 50 ng/mL of vascular endothelial growth factor ( VEGF ) for 24 hours or 100 μmol/L H 2 O 2 for 1 hour followed by 23‐hour incubation in normal culture media after washing were determined by quantitative real‐time polymerase chain reaction (n=3 in each group) and Western blot analysis, respectively. * P <0.05 vs control. C, Experimental design of adenovirus‐mediated overexpression in HCAECs using adenovirus vector of FABP 4 (Ad‐ FABP 4) or empty sequence (Ad‐Control) ( HCAEC ‐ OE ). D, Gene expression of FABP 4 in HCAEC ‐ OE (n=6 in each group). * P <0.05 vs Ad‐Control. E, Representative Western blot analysis of FABP 4 in HCAEC ‐ OE . F, Western blot analysis of nitric oxide synthase ( NOS 3) and phosphorylated NOS 3 ( pS 1177) in HCAEC ‐ OE treated with 0.5 μmol/L insulin or 50 ng/mL VEGF for 0.5 hours (n=3 in each group). * P <0.05. G and H, Gene expression of inflammatory cytokines (G) and adhesion‐related molecules (H) in HCAEC ‐ OE (n=6 in each group). * P <0.05 vs Ad‐Control. I, Western blot analysis of FABP 4 (exposure: light, L; dark, D) and GAPDH was performed using the cell lysate ( CL ) and conditioned medium ( CM ) of HCAECs supplemented with 0.5% BSA in the absence and presence of 10 μmol/L isoproterenol for 6 to 24 hours (n=3 in each group). * P <0.05. J, Secretion of FABP 4 for 24 hours in HCAEC ‐ OE measured using an enzyme‐linked immunosorbent assay kit (n=3 in each group). Values were normalized to total protein concentration of the cell lysate. * P <0.05 vs Ad‐Control. AU indicates arbitrary unit; Icam1, including intracellular adhesion; IL, interleukin; Itga5, integrin a 5; Itgb3, integrin b 3; Mcp1, monocyte chemotactic protein‐1; Sele, selectin E; Tnfa, tumor necrosis factor α.
Neonatal Human Dermal Fibroblasts, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+huvec+nucleofector+kit/pmc06779884-21-7-10?v=Lonza
Average 90 stars, based on 1 article reviews
neonatal human dermal fibroblasts - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Lonza huvec nucleofector kit
Overexpression and secretion of fatty acid–binding protein 4 (FABP4) in vascular endothelial cells. A and B, Gene (A) and protein (B) expression levels of FABP 4 in <t>human</t> <t>coronary</t> artery endothelial cells ( <t>HCAECs</t> ) treated with 50 ng/mL of vascular endothelial growth factor ( VEGF ) for 24 hours or 100 μmol/L H 2 O 2 for 1 hour followed by 23‐hour incubation in normal culture media after washing were determined by quantitative real‐time polymerase chain reaction (n=3 in each group) and Western blot analysis, respectively. * P <0.05 vs control. C, Experimental design of adenovirus‐mediated overexpression in HCAECs using adenovirus vector of FABP 4 (Ad‐ FABP 4) or empty sequence (Ad‐Control) ( HCAEC ‐ OE ). D, Gene expression of FABP 4 in HCAEC ‐ OE (n=6 in each group). * P <0.05 vs Ad‐Control. E, Representative Western blot analysis of FABP 4 in HCAEC ‐ OE . F, Western blot analysis of nitric oxide synthase ( NOS 3) and phosphorylated NOS 3 ( pS 1177) in HCAEC ‐ OE treated with 0.5 μmol/L insulin or 50 ng/mL VEGF for 0.5 hours (n=3 in each group). * P <0.05. G and H, Gene expression of inflammatory cytokines (G) and adhesion‐related molecules (H) in HCAEC ‐ OE (n=6 in each group). * P <0.05 vs Ad‐Control. I, Western blot analysis of FABP 4 (exposure: light, L; dark, D) and GAPDH was performed using the cell lysate ( CL ) and conditioned medium ( CM ) of HCAECs supplemented with 0.5% BSA in the absence and presence of 10 μmol/L isoproterenol for 6 to 24 hours (n=3 in each group). * P <0.05. J, Secretion of FABP 4 for 24 hours in HCAEC ‐ OE measured using an enzyme‐linked immunosorbent assay kit (n=3 in each group). Values were normalized to total protein concentration of the cell lysate. * P <0.05 vs Ad‐Control. AU indicates arbitrary unit; Icam1, including intracellular adhesion; IL, interleukin; Itga5, integrin a 5; Itgb3, integrin b 3; Mcp1, monocyte chemotactic protein‐1; Sele, selectin E; Tnfa, tumor necrosis factor α.
Huvec Nucleofector Kit, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+huvec+nucleofector+kit/pmc11024637-51-13-16?v=Lonza
Average 90 stars, based on 1 article reviews
huvec nucleofector kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Lonza human keratinocyte nucleofector kit
Overexpression and secretion of fatty acid–binding protein 4 (FABP4) in vascular endothelial cells. A and B, Gene (A) and protein (B) expression levels of FABP 4 in <t>human</t> <t>coronary</t> artery endothelial cells ( <t>HCAECs</t> ) treated with 50 ng/mL of vascular endothelial growth factor ( VEGF ) for 24 hours or 100 μmol/L H 2 O 2 for 1 hour followed by 23‐hour incubation in normal culture media after washing were determined by quantitative real‐time polymerase chain reaction (n=3 in each group) and Western blot analysis, respectively. * P <0.05 vs control. C, Experimental design of adenovirus‐mediated overexpression in HCAECs using adenovirus vector of FABP 4 (Ad‐ FABP 4) or empty sequence (Ad‐Control) ( HCAEC ‐ OE ). D, Gene expression of FABP 4 in HCAEC ‐ OE (n=6 in each group). * P <0.05 vs Ad‐Control. E, Representative Western blot analysis of FABP 4 in HCAEC ‐ OE . F, Western blot analysis of nitric oxide synthase ( NOS 3) and phosphorylated NOS 3 ( pS 1177) in HCAEC ‐ OE treated with 0.5 μmol/L insulin or 50 ng/mL VEGF for 0.5 hours (n=3 in each group). * P <0.05. G and H, Gene expression of inflammatory cytokines (G) and adhesion‐related molecules (H) in HCAEC ‐ OE (n=6 in each group). * P <0.05 vs Ad‐Control. I, Western blot analysis of FABP 4 (exposure: light, L; dark, D) and GAPDH was performed using the cell lysate ( CL ) and conditioned medium ( CM ) of HCAECs supplemented with 0.5% BSA in the absence and presence of 10 μmol/L isoproterenol for 6 to 24 hours (n=3 in each group). * P <0.05. J, Secretion of FABP 4 for 24 hours in HCAEC ‐ OE measured using an enzyme‐linked immunosorbent assay kit (n=3 in each group). Values were normalized to total protein concentration of the cell lysate. * P <0.05 vs Ad‐Control. AU indicates arbitrary unit; Icam1, including intracellular adhesion; IL, interleukin; Itga5, integrin a 5; Itgb3, integrin b 3; Mcp1, monocyte chemotactic protein‐1; Sele, selectin E; Tnfa, tumor necrosis factor α.
Human Keratinocyte Nucleofector Kit, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+huvec+nucleofector+kit/pm37423552-149-20-24?v=Lonza
Average 90 stars, based on 1 article reviews
human keratinocyte nucleofector kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Lonza human stem cell nucleofection buffer
Overexpression and secretion of fatty acid–binding protein 4 (FABP4) in vascular endothelial cells. A and B, Gene (A) and protein (B) expression levels of FABP 4 in <t>human</t> <t>coronary</t> artery endothelial cells ( <t>HCAECs</t> ) treated with 50 ng/mL of vascular endothelial growth factor ( VEGF ) for 24 hours or 100 μmol/L H 2 O 2 for 1 hour followed by 23‐hour incubation in normal culture media after washing were determined by quantitative real‐time polymerase chain reaction (n=3 in each group) and Western blot analysis, respectively. * P <0.05 vs control. C, Experimental design of adenovirus‐mediated overexpression in HCAECs using adenovirus vector of FABP 4 (Ad‐ FABP 4) or empty sequence (Ad‐Control) ( HCAEC ‐ OE ). D, Gene expression of FABP 4 in HCAEC ‐ OE (n=6 in each group). * P <0.05 vs Ad‐Control. E, Representative Western blot analysis of FABP 4 in HCAEC ‐ OE . F, Western blot analysis of nitric oxide synthase ( NOS 3) and phosphorylated NOS 3 ( pS 1177) in HCAEC ‐ OE treated with 0.5 μmol/L insulin or 50 ng/mL VEGF for 0.5 hours (n=3 in each group). * P <0.05. G and H, Gene expression of inflammatory cytokines (G) and adhesion‐related molecules (H) in HCAEC ‐ OE (n=6 in each group). * P <0.05 vs Ad‐Control. I, Western blot analysis of FABP 4 (exposure: light, L; dark, D) and GAPDH was performed using the cell lysate ( CL ) and conditioned medium ( CM ) of HCAECs supplemented with 0.5% BSA in the absence and presence of 10 μmol/L isoproterenol for 6 to 24 hours (n=3 in each group). * P <0.05. J, Secretion of FABP 4 for 24 hours in HCAEC ‐ OE measured using an enzyme‐linked immunosorbent assay kit (n=3 in each group). Values were normalized to total protein concentration of the cell lysate. * P <0.05 vs Ad‐Control. AU indicates arbitrary unit; Icam1, including intracellular adhesion; IL, interleukin; Itga5, integrin a 5; Itgb3, integrin b 3; Mcp1, monocyte chemotactic protein‐1; Sele, selectin E; Tnfa, tumor necrosis factor α.
Human Stem Cell Nucleofection Buffer, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+huvec+nucleofector+kit/pm30858616-206-18-23?v=Lonza
Average 90 stars, based on 1 article reviews
human stem cell nucleofection buffer - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Lonza human t cell nucleofector kit
Overexpression and secretion of fatty acid–binding protein 4 (FABP4) in vascular endothelial cells. A and B, Gene (A) and protein (B) expression levels of FABP 4 in <t>human</t> <t>coronary</t> artery endothelial cells ( <t>HCAECs</t> ) treated with 50 ng/mL of vascular endothelial growth factor ( VEGF ) for 24 hours or 100 μmol/L H 2 O 2 for 1 hour followed by 23‐hour incubation in normal culture media after washing were determined by quantitative real‐time polymerase chain reaction (n=3 in each group) and Western blot analysis, respectively. * P <0.05 vs control. C, Experimental design of adenovirus‐mediated overexpression in HCAECs using adenovirus vector of FABP 4 (Ad‐ FABP 4) or empty sequence (Ad‐Control) ( HCAEC ‐ OE ). D, Gene expression of FABP 4 in HCAEC ‐ OE (n=6 in each group). * P <0.05 vs Ad‐Control. E, Representative Western blot analysis of FABP 4 in HCAEC ‐ OE . F, Western blot analysis of nitric oxide synthase ( NOS 3) and phosphorylated NOS 3 ( pS 1177) in HCAEC ‐ OE treated with 0.5 μmol/L insulin or 50 ng/mL VEGF for 0.5 hours (n=3 in each group). * P <0.05. G and H, Gene expression of inflammatory cytokines (G) and adhesion‐related molecules (H) in HCAEC ‐ OE (n=6 in each group). * P <0.05 vs Ad‐Control. I, Western blot analysis of FABP 4 (exposure: light, L; dark, D) and GAPDH was performed using the cell lysate ( CL ) and conditioned medium ( CM ) of HCAECs supplemented with 0.5% BSA in the absence and presence of 10 μmol/L isoproterenol for 6 to 24 hours (n=3 in each group). * P <0.05. J, Secretion of FABP 4 for 24 hours in HCAEC ‐ OE measured using an enzyme‐linked immunosorbent assay kit (n=3 in each group). Values were normalized to total protein concentration of the cell lysate. * P <0.05 vs Ad‐Control. AU indicates arbitrary unit; Icam1, including intracellular adhesion; IL, interleukin; Itga5, integrin a 5; Itgb3, integrin b 3; Mcp1, monocyte chemotactic protein‐1; Sele, selectin E; Tnfa, tumor necrosis factor α.
Human T Cell Nucleofector Kit, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+huvec+nucleofector+kit/pmc04863925-206-17-22?v=Lonza
Average 90 stars, based on 1 article reviews
human t cell nucleofector kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Uptake and transfer of CD34Exo and exosomal miRNAs by endothelial cells in vitro and in vivo. Flow cytometry analysis of CD34+ cells (A) or exosomes isolated from CD34+ cells (B), transfected as indicated; confocal image of HUVECs treated with Cy3miRNA-CD34Exo (C); flow cytometry analysis of single cell suspensions from post-ischemic hindlimb tissue injected with R-PE-CD34Exo at 2h (D); % of cells uptaking exosomes (PE) from total number of each cell types quantified from Figure 5D (E), (n=3–5, *p<0.05).

Journal: Circulation research

Article Title: Angiogenic Mechanisms of Human CD34 + Stem Cell Exosomes in the Repair of Ischemic Hindlimb

doi: 10.1161/CIRCRESAHA.116.310557

Figure Lengend Snippet: Uptake and transfer of CD34Exo and exosomal miRNAs by endothelial cells in vitro and in vivo. Flow cytometry analysis of CD34+ cells (A) or exosomes isolated from CD34+ cells (B), transfected as indicated; confocal image of HUVECs treated with Cy3miRNA-CD34Exo (C); flow cytometry analysis of single cell suspensions from post-ischemic hindlimb tissue injected with R-PE-CD34Exo at 2h (D); % of cells uptaking exosomes (PE) from total number of each cell types quantified from Figure 5D (E), (n=3–5, *p<0.05).

Article Snippet: Human umbilical-vein endothelial cells (HUVECs) (Lonza Inc. Allendale, NJ) were maintained in endothelial growth medium-2 (EGM ™ -2; Lonza Inc.) and starved in EBM-2 medium containing 0.25% fetal bovine serum for 24 hours before cell assays were performed.

Techniques: In Vitro, In Vivo, Flow Cytometry, Isolation, Transfection, Injection

Overexpression and secretion of fatty acid–binding protein 4 (FABP4) in vascular endothelial cells. A and B, Gene (A) and protein (B) expression levels of FABP 4 in human coronary artery endothelial cells ( HCAECs ) treated with 50 ng/mL of vascular endothelial growth factor ( VEGF ) for 24 hours or 100 μmol/L H 2 O 2 for 1 hour followed by 23‐hour incubation in normal culture media after washing were determined by quantitative real‐time polymerase chain reaction (n=3 in each group) and Western blot analysis, respectively. * P <0.05 vs control. C, Experimental design of adenovirus‐mediated overexpression in HCAECs using adenovirus vector of FABP 4 (Ad‐ FABP 4) or empty sequence (Ad‐Control) ( HCAEC ‐ OE ). D, Gene expression of FABP 4 in HCAEC ‐ OE (n=6 in each group). * P <0.05 vs Ad‐Control. E, Representative Western blot analysis of FABP 4 in HCAEC ‐ OE . F, Western blot analysis of nitric oxide synthase ( NOS 3) and phosphorylated NOS 3 ( pS 1177) in HCAEC ‐ OE treated with 0.5 μmol/L insulin or 50 ng/mL VEGF for 0.5 hours (n=3 in each group). * P <0.05. G and H, Gene expression of inflammatory cytokines (G) and adhesion‐related molecules (H) in HCAEC ‐ OE (n=6 in each group). * P <0.05 vs Ad‐Control. I, Western blot analysis of FABP 4 (exposure: light, L; dark, D) and GAPDH was performed using the cell lysate ( CL ) and conditioned medium ( CM ) of HCAECs supplemented with 0.5% BSA in the absence and presence of 10 μmol/L isoproterenol for 6 to 24 hours (n=3 in each group). * P <0.05. J, Secretion of FABP 4 for 24 hours in HCAEC ‐ OE measured using an enzyme‐linked immunosorbent assay kit (n=3 in each group). Values were normalized to total protein concentration of the cell lysate. * P <0.05 vs Ad‐Control. AU indicates arbitrary unit; Icam1, including intracellular adhesion; IL, interleukin; Itga5, integrin a 5; Itgb3, integrin b 3; Mcp1, monocyte chemotactic protein‐1; Sele, selectin E; Tnfa, tumor necrosis factor α.

Journal: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Article Title: Ectopic Fatty Acid–Binding Protein 4 Expression in the Vascular Endothelium is Involved in Neointima Formation After Vascular Injury

doi: 10.1161/JAHA.117.006377

Figure Lengend Snippet: Overexpression and secretion of fatty acid–binding protein 4 (FABP4) in vascular endothelial cells. A and B, Gene (A) and protein (B) expression levels of FABP 4 in human coronary artery endothelial cells ( HCAECs ) treated with 50 ng/mL of vascular endothelial growth factor ( VEGF ) for 24 hours or 100 μmol/L H 2 O 2 for 1 hour followed by 23‐hour incubation in normal culture media after washing were determined by quantitative real‐time polymerase chain reaction (n=3 in each group) and Western blot analysis, respectively. * P <0.05 vs control. C, Experimental design of adenovirus‐mediated overexpression in HCAECs using adenovirus vector of FABP 4 (Ad‐ FABP 4) or empty sequence (Ad‐Control) ( HCAEC ‐ OE ). D, Gene expression of FABP 4 in HCAEC ‐ OE (n=6 in each group). * P <0.05 vs Ad‐Control. E, Representative Western blot analysis of FABP 4 in HCAEC ‐ OE . F, Western blot analysis of nitric oxide synthase ( NOS 3) and phosphorylated NOS 3 ( pS 1177) in HCAEC ‐ OE treated with 0.5 μmol/L insulin or 50 ng/mL VEGF for 0.5 hours (n=3 in each group). * P <0.05. G and H, Gene expression of inflammatory cytokines (G) and adhesion‐related molecules (H) in HCAEC ‐ OE (n=6 in each group). * P <0.05 vs Ad‐Control. I, Western blot analysis of FABP 4 (exposure: light, L; dark, D) and GAPDH was performed using the cell lysate ( CL ) and conditioned medium ( CM ) of HCAECs supplemented with 0.5% BSA in the absence and presence of 10 μmol/L isoproterenol for 6 to 24 hours (n=3 in each group). * P <0.05. J, Secretion of FABP 4 for 24 hours in HCAEC ‐ OE measured using an enzyme‐linked immunosorbent assay kit (n=3 in each group). Values were normalized to total protein concentration of the cell lysate. * P <0.05 vs Ad‐Control. AU indicates arbitrary unit; Icam1, including intracellular adhesion; IL, interleukin; Itga5, integrin a 5; Itgb3, integrin b 3; Mcp1, monocyte chemotactic protein‐1; Sele, selectin E; Tnfa, tumor necrosis factor α.

Article Snippet: Human coronary artery endothelial cells (HCAECs) and human coronary artery smooth muscle cells (HCASMCs) were purchased from Lonza.

Techniques: Over Expression, Binding Assay, Expressing, Incubation, Real-time Polymerase Chain Reaction, Western Blot, Plasmid Preparation, Sequencing, Enzyme-linked Immunosorbent Assay, Protein Concentration

Effects of the conditioned medium of Fabp4 ‐overexpressed endothelial cells in vascular smooth muscle cells. A, Experimental design of human coronary artery smooth muscle cells ( HCASMCs ) treated with the conditioned medium ( CM ) prepared by 24‐hour incubation of adenovirus vector of fatty acid–binding protein 4 (Ad‐ FABP 4)– and empty sequence (Ad‐Control)–transfected human coronary artery endothelial cells ( HCAECs ) in the absence and presence of 10 μg/mL anti‐ FABP 4 antibody ( FABP 4‐Ab) for 24 hours ( HCASMC ‐ CM ‐Ab). B, Gene expression of inflammatory cytokines and proliferation‐ and adhesion‐related molecules determined by quantitative real‐time polymerase chain reaction (PCR) in HCASMC ‐ CM ‐Ab (n=6 in each group). * P <0.05 vs CM of Ad‐Control–transfected HCAECs ( CM ‐Ad‐Control). † P <0.05 vs CM of Ad‐ FABP 4–transfected HCAECs ( CM ‐Ad‐ FABP 4). C and D, Proliferation of HCASMC ‐ CM supplemented with 5% FBS in the absence and presence of 10 μg/mL FABP 4‐Ab for 24 hours assessed by MTS (C) and bromodeoxyuridine (BrdU; D) assays (n=6 in each group). * P <0.05 vs CM ‐Ad‐Control. † P <0.05 vs CM ‐Ad‐ FABP 4. E, Migration of HCASMC ‐ CM supplemented with 0.5% BSA in the absence and presence of 10 μg/mL FABP 4‐Ab for 15 hours assessed by scratch wound assay (n=6 in each group). * P <0.05 vs CM ‐Ad‐Control. † P <0.05 vs CM ‐Ad‐ FABP 4. F, Experimental design of HCASMCs coincubated with Ad‐ FABP 4– and Ad‐Control–transfected HCAECs using insert transparent wells for 24 hours ( HCASMC ‐ TW ). G and H, Gene expression of inflammatory cytokines (G) and proliferation‐ and adhesion‐related molecules (H) determined by quantitative real‐time PCR in HCASMC ‐ TW (n=6 in each group). * P <0.05 vs coincubation using transparent wells with Ad‐Control–overexpressed HCAECs ( TW ‐Ad‐Control). AU indicates arbitrary unit; IL, interleukin; Itga5, integrin a 5; Itgb3, integrin b 3; Mcp1, monocyte chemotactic protein‐1; Pdgfra, platelet‐derived growth factor receptor α; Pdgfrb, platelet‐derived growth factor receptor β; Tnfa, tumor necrosis factor α.

Journal: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Article Title: Ectopic Fatty Acid–Binding Protein 4 Expression in the Vascular Endothelium is Involved in Neointima Formation After Vascular Injury

doi: 10.1161/JAHA.117.006377

Figure Lengend Snippet: Effects of the conditioned medium of Fabp4 ‐overexpressed endothelial cells in vascular smooth muscle cells. A, Experimental design of human coronary artery smooth muscle cells ( HCASMCs ) treated with the conditioned medium ( CM ) prepared by 24‐hour incubation of adenovirus vector of fatty acid–binding protein 4 (Ad‐ FABP 4)– and empty sequence (Ad‐Control)–transfected human coronary artery endothelial cells ( HCAECs ) in the absence and presence of 10 μg/mL anti‐ FABP 4 antibody ( FABP 4‐Ab) for 24 hours ( HCASMC ‐ CM ‐Ab). B, Gene expression of inflammatory cytokines and proliferation‐ and adhesion‐related molecules determined by quantitative real‐time polymerase chain reaction (PCR) in HCASMC ‐ CM ‐Ab (n=6 in each group). * P <0.05 vs CM of Ad‐Control–transfected HCAECs ( CM ‐Ad‐Control). † P <0.05 vs CM of Ad‐ FABP 4–transfected HCAECs ( CM ‐Ad‐ FABP 4). C and D, Proliferation of HCASMC ‐ CM supplemented with 5% FBS in the absence and presence of 10 μg/mL FABP 4‐Ab for 24 hours assessed by MTS (C) and bromodeoxyuridine (BrdU; D) assays (n=6 in each group). * P <0.05 vs CM ‐Ad‐Control. † P <0.05 vs CM ‐Ad‐ FABP 4. E, Migration of HCASMC ‐ CM supplemented with 0.5% BSA in the absence and presence of 10 μg/mL FABP 4‐Ab for 15 hours assessed by scratch wound assay (n=6 in each group). * P <0.05 vs CM ‐Ad‐Control. † P <0.05 vs CM ‐Ad‐ FABP 4. F, Experimental design of HCASMCs coincubated with Ad‐ FABP 4– and Ad‐Control–transfected HCAECs using insert transparent wells for 24 hours ( HCASMC ‐ TW ). G and H, Gene expression of inflammatory cytokines (G) and proliferation‐ and adhesion‐related molecules (H) determined by quantitative real‐time PCR in HCASMC ‐ TW (n=6 in each group). * P <0.05 vs coincubation using transparent wells with Ad‐Control–overexpressed HCAECs ( TW ‐Ad‐Control). AU indicates arbitrary unit; IL, interleukin; Itga5, integrin a 5; Itgb3, integrin b 3; Mcp1, monocyte chemotactic protein‐1; Pdgfra, platelet‐derived growth factor receptor α; Pdgfrb, platelet‐derived growth factor receptor β; Tnfa, tumor necrosis factor α.

Article Snippet: Human coronary artery endothelial cells (HCAECs) and human coronary artery smooth muscle cells (HCASMCs) were purchased from Lonza.

Techniques: Incubation, Plasmid Preparation, Binding Assay, Sequencing, Transfection, Expressing, Real-time Polymerase Chain Reaction, Migration, Scratch Wound Assay Assay, Derivative Assay

Effects of the conditioned medium of Fabp4 ‐overexpressed endothelial cells in vascular endothelial cells. A, Experimental design of human coronary artery endothelial cells ( HCAECs ) treated with the conditioned medium ( CM ) prepared by 24‐hour incubation of adenovirus vector of fatty acid–binding protein 4 (Ad‐ FABP 4)– and empty sequence (Ad‐Control)–transfected HCAECs ( HCAEC ‐ CM ) in the absence and presence of 10 μg/mL anti‐ FABP 4 antibody ( FABP 4‐Ab) for 24 hours ( HCAEC ‐ CM ‐Ab). B, Gene expression of inflammatory cytokines and adhesion‐related molecules determined by quantitative real‐time polymerase chain reaction (PCR) in HCAEC ‐ CM (n=6 in each group). * P <0.05 vs CM of Ad‐Control–overexpressed HCAECs ( CM ‐Ad‐Control). C, Gene expression of inflammatory cytokines and adhesion‐related molecules determined by quantitative real‐time PCR in HCAEC ‐ CM ‐Ab (n=4 in each group). * P <0.05 vs FABP 4‐Ab (−). D, Experimental design of HCAECs coincubated with Ad‐ FABP 4– and Ad‐Control–transfected HCAECs using insert transparent wells for 24 hours ( HCAEC ‐ TW ). E and F, Gene expression of inflammatory cytokines (E) and adhesion‐related molecules (F) determined by quantitative real‐time PCR in HCAEC ‐ TW (n=6 in each group). * P <0.05 vs coincubation using transparent wells with Ad‐Control–overexpressed HCAECs ( TW ‐Ad‐Control). AU indicates arbitrary unit; Icam1, including intracellular adhesion; IL, interleukin; Itga5, integrin a 5; Itgb3, integrin b 3; Mcp1, monocyte chemotactic protein‐1; Sele, selectin E; Tnfa, tumor necrosis factor α.

Journal: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Article Title: Ectopic Fatty Acid–Binding Protein 4 Expression in the Vascular Endothelium is Involved in Neointima Formation After Vascular Injury

doi: 10.1161/JAHA.117.006377

Figure Lengend Snippet: Effects of the conditioned medium of Fabp4 ‐overexpressed endothelial cells in vascular endothelial cells. A, Experimental design of human coronary artery endothelial cells ( HCAECs ) treated with the conditioned medium ( CM ) prepared by 24‐hour incubation of adenovirus vector of fatty acid–binding protein 4 (Ad‐ FABP 4)– and empty sequence (Ad‐Control)–transfected HCAECs ( HCAEC ‐ CM ) in the absence and presence of 10 μg/mL anti‐ FABP 4 antibody ( FABP 4‐Ab) for 24 hours ( HCAEC ‐ CM ‐Ab). B, Gene expression of inflammatory cytokines and adhesion‐related molecules determined by quantitative real‐time polymerase chain reaction (PCR) in HCAEC ‐ CM (n=6 in each group). * P <0.05 vs CM of Ad‐Control–overexpressed HCAECs ( CM ‐Ad‐Control). C, Gene expression of inflammatory cytokines and adhesion‐related molecules determined by quantitative real‐time PCR in HCAEC ‐ CM ‐Ab (n=4 in each group). * P <0.05 vs FABP 4‐Ab (−). D, Experimental design of HCAECs coincubated with Ad‐ FABP 4– and Ad‐Control–transfected HCAECs using insert transparent wells for 24 hours ( HCAEC ‐ TW ). E and F, Gene expression of inflammatory cytokines (E) and adhesion‐related molecules (F) determined by quantitative real‐time PCR in HCAEC ‐ TW (n=6 in each group). * P <0.05 vs coincubation using transparent wells with Ad‐Control–overexpressed HCAECs ( TW ‐Ad‐Control). AU indicates arbitrary unit; Icam1, including intracellular adhesion; IL, interleukin; Itga5, integrin a 5; Itgb3, integrin b 3; Mcp1, monocyte chemotactic protein‐1; Sele, selectin E; Tnfa, tumor necrosis factor α.

Article Snippet: Human coronary artery endothelial cells (HCAECs) and human coronary artery smooth muscle cells (HCASMCs) were purchased from Lonza.

Techniques: Incubation, Plasmid Preparation, Binding Assay, Sequencing, Transfection, Expressing, Real-time Polymerase Chain Reaction

Effects of exogenous fatty acid–binding protein 4 (FABP4) treatment in vascular endothelial cells. A, Experimental design of human coronary artery endothelial cells ( HCAECs ) treated with 200 nmol/L recombinant FABP 4 ( HCAEC ‐Rec) in the absence and presence of 10 μg/mL anti‐ FABP 4 antibody ( FABP 4‐Ab) for 24 hours ( HCAEC ‐Rec‐Ab). B, Gene expression of inflammatory cytokines and adhesion‐related molecules determined by quantitative real‐time polymerase chain reaction (PCR) in HCAEC ‐Rec (n=3 in each group). * P <0.05 vs Rec‐ FABP 4 (−). C, Gene expression of inflammatory cytokines and adhesion‐related molecules determined by quantitative real‐time PCR in HCAEC ‐Rec‐Ab (n=3 in each group). * P <0.05 vs FABP 4‐Ab (−). D, Representative Western blot analysis of endogenous FABP 4, His‐tagged FABP 4 (His‐ FABP 4), and GAPDH was performed using the cell lysate ( CL ) and conditioned medium ( CM) of HCAECs treated with 0 to 200 nmol/L His‐tagged Rec‐ FABP 4 for 6 hours. E, Western blot analysis of nitric oxide synthase 3 ( NOS 3) phosphorylated NOS 3 ( pS 1177) in HCAEC ‐Rec‐Ab followed by stimulation with 50 ng/mL vascular endothelial growth factor ( VEGF ) for 0.5 hours (n=3 in each group). * P <0.05. AU indicates arbitrary unit; Icam1, including intracellular adhesion; IL, interleukin; Itga5, integrin a 5; Itgb3, integrin b 3; Mcp1, monocyte chemotactic protein‐1; Sele, selectin E; Tnfa, tumor necrosis factor α.

Journal: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Article Title: Ectopic Fatty Acid–Binding Protein 4 Expression in the Vascular Endothelium is Involved in Neointima Formation After Vascular Injury

doi: 10.1161/JAHA.117.006377

Figure Lengend Snippet: Effects of exogenous fatty acid–binding protein 4 (FABP4) treatment in vascular endothelial cells. A, Experimental design of human coronary artery endothelial cells ( HCAECs ) treated with 200 nmol/L recombinant FABP 4 ( HCAEC ‐Rec) in the absence and presence of 10 μg/mL anti‐ FABP 4 antibody ( FABP 4‐Ab) for 24 hours ( HCAEC ‐Rec‐Ab). B, Gene expression of inflammatory cytokines and adhesion‐related molecules determined by quantitative real‐time polymerase chain reaction (PCR) in HCAEC ‐Rec (n=3 in each group). * P <0.05 vs Rec‐ FABP 4 (−). C, Gene expression of inflammatory cytokines and adhesion‐related molecules determined by quantitative real‐time PCR in HCAEC ‐Rec‐Ab (n=3 in each group). * P <0.05 vs FABP 4‐Ab (−). D, Representative Western blot analysis of endogenous FABP 4, His‐tagged FABP 4 (His‐ FABP 4), and GAPDH was performed using the cell lysate ( CL ) and conditioned medium ( CM) of HCAECs treated with 0 to 200 nmol/L His‐tagged Rec‐ FABP 4 for 6 hours. E, Western blot analysis of nitric oxide synthase 3 ( NOS 3) phosphorylated NOS 3 ( pS 1177) in HCAEC ‐Rec‐Ab followed by stimulation with 50 ng/mL vascular endothelial growth factor ( VEGF ) for 0.5 hours (n=3 in each group). * P <0.05. AU indicates arbitrary unit; Icam1, including intracellular adhesion; IL, interleukin; Itga5, integrin a 5; Itgb3, integrin b 3; Mcp1, monocyte chemotactic protein‐1; Sele, selectin E; Tnfa, tumor necrosis factor α.

Article Snippet: Human coronary artery endothelial cells (HCAECs) and human coronary artery smooth muscle cells (HCASMCs) were purchased from Lonza.

Techniques: Binding Assay, Recombinant, Expressing, Real-time Polymerase Chain Reaction, Western Blot